Skip to main content

Clinical Research from Clinical Investigation Services

Call Today to Qualify

Open Hours

Monday – Friday 8 am to 5pm

Have you been diagnosed with Type 2 Diabetes? Are you currently taking metformin?

The REIMAGINE 2 trial by Novo Nordisk compares the efficacy of CagriSema in lowering the blood sugar and body weight of people with type 2 diabetes who are treated with metformin, with or without a semaglutide inhibitor. The efficacy of the study drug will be compared to semaglutide, cagrilintide, and a placebo.

Dr. John Agaiby, MD is the leading physician (principal investigator) for this trial at our clinic in Gurnee, IL. We are currently accepting new patients for this study.

For more information on this clinical trial, please call our Gurnee clinic at 847-599-2492 and ask to speak to our recruiters.

For more information about diabetes, click here to be redirected to the Center for Disease Control's (CDC) website, where lots of helpful information and resources are available.

Trial Protocol: NN9388-4896

General Contact Form
When Should We Contact You?
When would it be best for a member of our team to contact you? Please select all that apply.
How Did You Hear About Us?
How did you hear about Clinical Investigation Specialists? Please select all that apply.
If you heard about CIS from someone, please let us know! This field is not required. 
CIS Research is a robust, multi-site network of clinical trial sites. This means we are always running many types of research studies. We would like to contact you if there is a trial that you may be a qualified candidate for in the future. Please tell us a little bit about the types of trials you are interested in.
Please provide any other information you think we should know before a member of our team contacts you.

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile